Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIE-ERAS-RARC Study
jRCT1041250174Recruiting
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ninjinyoeito in bladder cancer (2 arms). Primary endpoint: Length of stay. Started Jan 2026; status: recruiting.
02
Drugs
ninjinyoeito
03
Conditions
bladder cancer
Beyond the preview
Go deeper on jRCT1041250174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041250174.